Zhihao Ding is the Head of Global Human Genetics and Animal Health Genomics at Boehringer Ingelheim. His team specializes in statistical genomics, machine learning, and animal genomics, focusing on target discovery, biomarker discovery, and patient stratification across various disease areas. Disease priorities include fibrosis, cardiometabolic diseases, cancer immunology, and oncology. Zhihao leads the genetic strategy for Boehringer's Biobank portfolio, overseeing study design, data access, data generation, and study execution. His team is dedicated to understanding causal human biology through genetics across different diseases and modelling longitudinal patient journeys. He was trained as a statistical geneticist at the University of Cambridge.